(761): A randomized, double-blind, placebo-controlled, multicenter phase IIb study to evaluate the efficacy and safety of multiple alvimopan dosage regimens for the treatment of gastrointestinal adverse events (GIAEs) associated with opioid use in subjects
Journal of Pain（2006）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined